Before lung cancer therapy begins, diagnostic findings and treatment readiness shape care, creating opportunities for pharmacists to help patients start safely.
|Articles|June 18, 2020
Pharmacy Industry Outlook for Technicians
Experts discuss insights from NHA's 2019 Industry Outlook research from employers of pharmacy technicians to better understanding their needs and the value of certification for this role.
Advertisement
During episode 3, host Jeremy Sasser and co-host Jessica Langley, executive director for education and advocacy at NHA, share insights from NHA's 2019 Industry Outlook research,
Advertisement
Related to this article
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
October’s hematology coverage highlighted first-line pirtobrutinib, questions about myeloma treatment duration and early intervention, and pharmacists’ roles in medication safety and access.
October’s oncology coverage highlighted new treatment options in rectal, breast, and prostate cancers, alongside longer-term survival findings and concerns about reduced-frequency immunotherapy.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
ESMO 2026 lung cancer trials reshape first-line care with tarlatamab maintenance, stronger KRAS G12C results, and TROP2 ADC gains, raising pharmacy monitoring demands.
Advertisement
Advertisement
Trending on Pharmacy Times
1
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
2
Nicotine Vaping Linked to Lower Vascular Function in Young Adults
3
Over Half of RSV-Related Deaths in Hospitalized Adults Occur After Discharge
4
Cystatin C and the Future of Kidney Function Assessment
5